{"title":"缉毒局再次扩大虚拟丁丙诺啡诱导的灵活性","authors":"Gary Enos","doi":"10.1002/adaw.34341","DOIUrl":null,"url":null,"abstract":"<p>As the Drug Enforcement Administration (DEA) adds another year to flexibilities for prescribing of buprenorphine through telemedicine, evidence from the addiction treatment community continues to suggest the benefits of making this COVID-era change permanent.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"36 46","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DEA again extends flexibility for virtual buprenorphine induction\",\"authors\":\"Gary Enos\",\"doi\":\"10.1002/adaw.34341\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>As the Drug Enforcement Administration (DEA) adds another year to flexibilities for prescribing of buprenorphine through telemedicine, evidence from the addiction treatment community continues to suggest the benefits of making this COVID-era change permanent.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"36 46\",\"pages\":\"1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34341\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34341","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
DEA again extends flexibility for virtual buprenorphine induction
As the Drug Enforcement Administration (DEA) adds another year to flexibilities for prescribing of buprenorphine through telemedicine, evidence from the addiction treatment community continues to suggest the benefits of making this COVID-era change permanent.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
